pt 141

PT-141

Bremelanotide

PT-141 (bremelanotide) enhances desire via brain pathways—not just blood flow—supporting satisfying intimacy for men and women with clinician guidance.

✅ Peptide for enhancing libido in men and women
✅ Works through the brain’s melanocortin system—not blood flow alone
✅ Rapid onset (45–60 minutes) with lasting effects up to 12 hours
✅ Improves desire, arousal, and satisfaction for both partners
✅ Avoid use in pregnancy or uncontrolled cardiovascular disease

🌿 Understanding PT-141 (Bremelanotide)

What It Is

PT-141, also known as bremelanotide, is an FDA-approved peptide therapy used to enhance sexual desire and performance in both men and women. Unlike medications that act on the vascular system (like Viagra® or Cialis®), PT-141 works directly on the central nervous system, targeting the melanocortin receptors in the brain that influence sexual arousal and motivation.

This unique mechanism allows PT-141 to stimulate desire, intimacy, and satisfaction naturally—without relying on blood-flow-only effects.


💊 Clinical Application

PT-141 can be used by:

  • ✅ Women experiencing low libido or sexual interest disorder (HSDD)
  • ✅ Men with erectile dysfunction or reduced arousal not fully responsive to PDE5 inhibitors
  • ✅ Individuals seeking to enhance intimacy, confidence, and sexual wellness

At Kaizen Health, PT-141 is incorporated into personalized sexual-health protocols that address both the physical and emotional aspects of sexual well-being.

Typical use: A small, subcutaneous injection approximately 45 minutes before intimacy, with effects lasting 6–12 hours.


⚖️ Clinical Outcomes

Clinical trials and real-world studies show PT-141 can significantly improve:

  • Sexual desire and satisfaction in both men and women
  • Erectile firmness and duration in men
  • Response to sexual cues and mood related to intimacy
  • Confidence and relationship satisfaction

Women (RECONNECT studies):

  • Up to 25% increase in satisfying sexual events
  • Significant improvement in desire and reduced distress scores

Men:

  • Onset within 30–60 minutes, with effects lasting up to 12 hours
  • Improved erectile response independent of nitric-oxide mechanisms

⏱️ Timeline of Results

  • 45–60 minutes: Typical onset of effect
  • 6–12 hours: Duration of enhanced libido or performance
  • 1–2 doses per week: Common frequency for maintenance or as-needed use

Some users notice improvements in sexual motivation and confidence over several weeks of consistent use.


⚠️ Potential Side Effects

Most side effects are mild and short-lived. They may include:

  • Flushing or warmth
  • Mild nausea (especially on first dose)
  • Headache
  • Temporary increase in blood pressure
  • Injection-site redness or tenderness

Nausea typically subsides after the first few doses and can be minimized by starting with lower doses or using the nasal form if prescribed.


🚫 Contraindications

PT-141 should not be used in individuals who have:

  • Uncontrolled hypertension or cardiovascular disease
  • Pregnancy or breastfeeding
  • Known hypersensitivity to bremelanotide or formulation ingredients

Caution is advised in patients taking antihypertensive medications or those prone to nausea.


🌱 The Kaizen Health Approach

At Kaizen Health, sexual health is viewed as an essential part of whole-body wellness. We integrate PT-141 therapy with:

  • Hormone balance optimization (testosterone, estrogen, thyroid, adrenal)
  • Lifestyle coaching focused on stress, sleep, and connection
  • Nutrient and supplement support for vascular and neurotransmitter health
  • Mind-body techniques that promote confidence and relationship well-being

Our goal is to help patients restore intimacy, energy, and vitality in a natural, personalized way.

Non-Member Price: $200 / 3-month supply
Member Price: $150 / 3-month supply

References
  1. Kingsberg SA, Clayton AH, Portman DJ, et al. Bremelanotide for the treatment of hypoactive sexual desire disorder in premenopausal women: two randomized phase 3 trials (RECONNECT 1 & 2). Obstet Gynecol. 2019;134(5):899–908.
  2. Diamond LE, et al. Bremelanotide (PT-141) for the treatment of male erectile dysfunction: results of randomized, placebo-controlled trials. J Sex Med. 2004;1(3):193–203.
  3. Clayton AH, Kingsberg SA. Mechanisms and clinical role of melanocortin receptor agonists in female sexual function. J Sex Med. 2020;17(2):254–265.
  4. FDA Center for Drug Evaluation and Research. Vyleesi (bremelanotide) Prescribing Information. U.S. FDA, 2019.
  5. Shadiack AM, et al. Melanocortin receptor agonists and sexual function: from basic science to clinical application. Front Endocrinol (Lausanne). 2021;12:634124.
Legal Disclaimer

Even though our partner pharmacies use only FDA-approved ingredients that are pharmaceutical-grade and highly regulated, compounded prescriptions are not FDA approved. The appearance, contents, and dosage of the vial may vary based on your personalized prescription, and individual results may vary.

These statements have not been evaluated by the FDA. This product/treatment is not intended to diagnose, treat, cure, or prevent any disease. All medical treatments are provided only after a licensed healthcare provider determines medical eligibility. Medical eligibility required. Individual results may vary. Must be 18 years or older.

Dr. Steven Baum, MD

steve kaizen
NPI Number

1205339090

Medical Licenses

Arizona, California, Idaho, Montana, Nevada, Ohio, Utah, Washington, Wyoming

DEA Licenses

Arizona, Utah, Washington
(Controlled substances can only be prescribed in these states)

Years Practicing

6 Years

Certifications

American Board of Family Medicine
American Board of Obesity Medicine
National Academy of Sports Medicine

Education

B.S. in Exercise & Sport Science – University of Utah
M.H.A. – Louisiana State University
M.D. – The Ohio State University College of Medicine

Other Products

View All Products

Share With Others

Our Client Experience

115+ Reviews

Hear from Kaizen Clients: